Docetaxel 20mg/0.5ml & 80mg/2ml injection Vial
Docetaxel is an antineoplastic agent that acts by disrupting the microtubular network in cells that is essential for mitotic and interphase cellular functions. Docetaxel binds to free tubulin and promotes the assembly of tubulin into stable microtubules while simultaneously inhibiting their disassembly. This leads to the production of microtubule bundles without normal function and to the stabilization of microtubules, which results in the inhibition of mitosis in cells. Docetaxel’s binding to microtubules does not alter the number of protofilaments in the bound microtubules, a feature which differs from most spindle poisons currently in clinical use.
Share Now
Additional Information
Name | Docetaxel 20mg/0.5ml & 80mg/2ml injection Vial |
Description | Docetaxel is an antineoplastic agent that acts by disrupting the microtubular network in cells that is essential for mitotic and interphase cellular functions. Docetaxel binds to free tubulin and promotes the assembly of tubulin into stable microtubules while simultaneously inhibiting their disassembly. This leads to the production of microtubule bundles without normal function and to the stabilization of microtubules, which results in the inhibition of mitosis in cells. Docetaxel’s binding to microtubules does not alter the number of protofilaments in the bound microtubules, a feature which differs from most spindle poisons currently in clinical use. |
Active Ingredient | Docetaxel |
Indication | Docetaxel in combination therapy is indicated for the following cancer types:
|
Strengths | 20mg/0.5ml |
Business Partner | Vianex |
Origin | Greece |
Related Products
Related products
Dasatinib
Rated 0 out of 5Doxorubicin Injection
Rated 0 out of 5Pataxel 30mg, 100mg & 300mg injection vial
Rated 0 out of 5Gemnil 200mg & 1gm injection Vial
Rated 0 out of 5
Disclaimer
Pharma Solution is the marketing agent and Distributor for the listed products for the Gulf and MENA region. The products are either registered and approved by the respective local health authority or contracted by the MAH to supply to the end users on a named patient basis. Some products such as Orphan drugs, rare diseases medicines are imported based on special import permits and as per need of the Hospitals in compliance with full documentation.